Scrip has formed a list of 18 artificial intelligence companies using novel technologies to discover drug targets, highlighting those with pharma partnerships or internal development pipelines that could be disruptive to the innovative life science sector.
There has been a lot of hype around the use of artificial intelligence (AI) for drug discovery and development, and a batch of start-ups have emerged in
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?